Mindset Pharma (MSSTF) Stock Price, News & Analysis

Company Overview

Mindset Pharma Inc. (OTCMKTS: MSSTF) is a clinical-stage biotechnology company headquartered in Montreal, Canada, focused on developing next-generation psychedelics to address a range of central nervous system disorders. The company applies rational drug design and medicinal chemistry to create novel molecules inspired by naturally occurring psychedelics, aiming to enhance therapeutic benefits while minimizing adverse effects. Mindset’s approach emphasizes improved pharmacokinetic and safety profiles, with the goal of delivering more consistent and reliable patient outcomes compared to traditional psychedelic compounds.

The company has assembled a preclinical pipeline of proprietary compounds targeting indications such as treatment-resistant depression, post-traumatic stress disorder (PTSD) and other neuropsychiatric conditions. Mindset’s lead programs utilize analogues of classic psychedelic agents, including psilocybin and MDMA, engineered for optimized dosing regimens and reduced hallucinogenic intensity. Preclinical studies conducted in collaboration with academic and contract research organizations support the potential for these candidates to induce rapid and durable neuroplastic changes with improved tolerability.

Founded in 2020, Mindset Pharma leverages partnerships with research institutions and contract development and manufacturing organizations to advance its programs toward clinical trials. The company’s management team includes industry veterans with experience in pharmaceutical R&D, regulatory affairs and commercialization. As Mindset progresses its pipeline through preclinical and clinical stages, it seeks to position itself at the forefront of innovation in psychedelic-inspired therapeutics for mental health.

Key Stats

• Today's Range: $0.54 to $0.54
• 50-Day Range: $0.54 to $0.54
• 52-Week Range: $0.16 to $0.56
• Volume: N/A
• Average Volume: 33,313 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MSSTF Stock Analysis - Frequently Asked Questions

How have MSSTF shares performed this year?

Mindset Pharma's stock was trading at $0.5381 at the start of the year. Since then, MSSTF stock has increased by 0.0% and is now trading at $0.5381.

How do I buy shares of Mindset Pharma?

Shares of MSSTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MSSTF
• CIK: N/A
• Web: www.mindsetpharma.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A